Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Urology

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Time to progression · patients with non‐muscle invasive bladder cancer

Gemcitabine showed no clear difference in time to progression (absolute effect size estimates based on… compared with saline (low certainty).

1 finding from 1 review

Intravesical gemcitabine for non‐muscle invasive bladder cancer 2021 · Cochrane Headline outcomes only
HR 0.96 [0.19, 4.71]
2 studies · 654 participants
Low